TransMedics Group, Inc. (TMDX) NASDAQ

118.80

-6.94(-5.52%)

Updated at August 06 04:00PM

Currency In USD

Valuation

Market Cap2.07B
Enterprise Value2.25B
P/E Ratio56.22
PEG Ratio1.24
Price/Sales Ratio7.62
Price/Book Ratio12.67
Enterprise/Revenue7.73
Enterprise/EBITDA40.23

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.13
Operating Margin0.14

Management Effectiveness

Return On Assets0.08
Return On Equity0.28

Income Statement

Revenue441.54M
Revenue/Share15.67
Gross Profit262.08M
EBITDA69.95M
Net Income35.46M
Diluted EPS1.01

Balance Sheet

Total Cash400.58M
Total Cash/Share11.81
Total Debt518.82M
Total Debt/Equity1.44
Current Ratio9.86
Book Value Per Share9.38

Price History

52-Week Change-23.89
52-Week High177.37
52-Week Low55
Moving Average 50 Days124.54
Moving Average 200 Days91.44

Statistics

Average Volume1.11M
Shares Outstanding34.09M
% Held by Institutions115.61

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A